Hint mode is switched on Switch off

Apellis Pharmaceuticals, ordinary share
APLS, US03753U1060

Add a stock to WL
Choose all Reset all
Apellis Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Apellis Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    APLS
  • Placement
    09.11.2017
  • Lock up period
    180
  • Number of papers
    10,714,000
  • Volume of raised funds
    150 mln USD
  • Final placement price
    14 USD
  • Price change since placement date
    193.07%
  • By capitalization
    689.6 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    APLS
  • Placement
    19.04.2018
  • Lock up period
    180
  • Number of papers
    5,500,000
  • Volume of raised funds
    140.25 mln USD
  • Placement share
    9.84%
  • Final placement price
    25.5 USD
  • Price change since placement date
    60.9%
  • By capitalization
    1,424.76 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    APLS
  • Placement
    07.01.2020
  • Lock up period
    180
  • Number of papers
    7,000,000
  • Volume of raised funds
    211.33 mln USD
  • Placement share
    9.87%
  • Final placement price
    30.19 USD
  • Price change since placement date
    35.91%
  • By capitalization
    2,141.62 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
III q eng
IV q eng
Show all Hide

Indicators

News

14/05/2026 Apellis Pharmaceuticals: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
30/03/2026 Apellis Pharmaceuticals: Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
12/01/2026 Apellis Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
01/07/2025 Apellis Pharmaceuticals: Entry Into A Material Definitive Agreement
03/06/2025 Apellis Pharmaceuticals: Submission Of Matters To A Vote Of Security Holders
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.